Human papillomavirus vaccine (AnGes)

N/A

Report date: 2024/11/09 20:00:08

Base Information

Drug NameHuman papillomavirus vaccine (AnGes)
Drug Alias NameCIN therapeutic vaccineHPV vaccine + lactobacillus carrierOral HPV vaccineGLBL101cBLS-ILB-E710c
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCervical Intraepithelial Neoplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBioleaders Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioleaders Corporation
Active IndicationsN/A
Inactive IndicationsCervical Intraepithelial Neoplasia

Other Information

ATC CodeN/A
Related LinksN/A